SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-003983
Filing Date
2017-05-09
Accepted
2017-05-09 16:17:08
Documents
51
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20170331x10q.htm 10-Q 848845
2 EX-10.1 zyne-20170331ex101f69f67.htm EX-10.1 118016
3 EX-31.1 zyne-20170331ex3119b3487.htm EX-31.1 13686
4 EX-31.2 zyne-20170331ex312e41a7b.htm EX-31.2 13485
5 EX-32.1 zyne-20170331ex321d8dbc8.htm EX-32.1 6168
6 EX-32.2 zyne-20170331ex3227a238a.htm EX-32.2 6184
7 GRAPHIC zyne20170331x10q001.jpg GRAPHIC 35848
  Complete submission text file 0001558370-17-003983.txt   3704040

Data Files

Seq Description Document Type Size
8 EX-101.INS zyne-20170331.xml EX-101.INS 748618
9 EX-101.SCH zyne-20170331.xsd EX-101.SCH 25190
10 EX-101.CAL zyne-20170331_cal.xml EX-101.CAL 29555
11 EX-101.DEF zyne-20170331_def.xml EX-101.DEF 101230
12 EX-101.LAB zyne-20170331_lab.xml EX-101.LAB 233514
13 EX-101.PRE zyne-20170331_pre.xml EX-101.PRE 197561
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 17826634
SIC: 2834 Pharmaceutical Preparations